2010 Competition Doctors Pharma 
Pharmaceutical Technology
MARCH 24, 2023
Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. For example, AbbVie had obtained more than 100 patents for Humira.
PM360
NOVEMBER 29, 2022
1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade. Orchestrated omnichannel engagement has grown into a buzz phrase for commercial teams ever since they started using digital communications channels to engage with doctors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Contrarian Sales Techniques
FEBRUARY 26, 2023
There was an article that examine the market for generic medicines in the Malaysia, following the introduction of the first generic patent in 2010 and the introduction of generic patent law in 2012. There are some countries in the world that do not require waiting for patent expiration to produce a generic version of a drug.
Evolve Your Success
MAY 16, 2023
We try to model our clinics like a regular doctor’s office. We modeled our practice like a regular doctor’s office. By running it as a normal doctor’s office and making the visits easy to attend, not starting at 5:00 AM and closing at noon, we accept all insurances that will get credentialed with us, even Medicaid.
Clarivate
APRIL 18, 2024
Humana is following a similar growth strategy as it sharpens competition with UnitedHealthcare in the Medicare Advantage sector. Signify’s healthcare platform also assists 65,000 provider partners to participate in value-based care with nearly 1 million attributed lives Oak Street Health acquisition May 2023 CVS acquired Oak Street for $10.6
Expert insights. Personalized for you.
59 
Let's personalize your content